Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-04-16

Clinical Trial Update: Short Term Spironolactone for Prevention of Acute Kidney Injury After Cardiac Surgery [NA]

View source ↗

Summary

A clinical trial is investigating short-term spironolactone to prevent acute kidney injury after cardiac surgery; the current trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Spironolactone (spironolactone)

Snippet

Sponsor: Instituto Nacional de Cardiologia Ignacio Chavez | Conditions: Acute Kidney Injuries, Kidney Injuries, Acute | NA | Status: UNKNOWN